-
Stocks in News: Primerica (NYSE:PRI), iCAD (NASDAQ:ICAD), Finish Line Inc. (NASDAQ:FINL), Biogen Idec Inc. (NASDAQ:BIIB), Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
On last trading day Primerica, Inc. (NYSE:PRI) advanced 0.28% to close at $51.00. Its volatility for the week is 2.02% while volatility for the month is 1.73%. PRI’s sales growth for past 5 years was -9.60% and its EPS growth for past 5 years was -12.70%. Primerica, Inc. (NYSE:PRI) monthly performance is -2.78%. On March […]
-
Stocks in Focus: Biogen Idec Inc. (NASDAQ:BIIB), GlobalSCAPE (NYSEMKT:GSB), Weibo Corporation (NASDAQ:WB), Swisher Hygiene (NASDAQ:SWSH), Sears Hometown and Outlet Stores (NASDAQ:SHOS)
On Tuesday shares of Biogen Idec Inc. (NASDAQ:BIIB) closed at $452.71. Company’s sales growth for last 5 years was 17.30% and EPS growth for next 5 years is recorded as 18.03%. Biogen Idec Inc. (NASDAQ:BIIB), which was heralded last week for results of an Alzheimer’s drug trial, has shortened its name and chosen a new […]
-
News Buzz: Nuverra Environmental Solutions (NYSE:NES), Biogen Idec Inc. (NASDAQ:BIIB), Alibaba Group Holding Ltd (NYSE:BABA), Ohio Valley Banc Corp. (NASDAQ:OVBC), Celgene (NASDAQ:CELG)
On Friday shares of Nuverra Environmental Solutions, Inc. (NYSE:NES) closed at $3.26. Company’s sales growth for last 5 years was 118.70% and EPS growth for next 5 years is recorded as 25.00%. Analysts at Roth Capital reduced their target price on shares of Nuverra Environmental Solutions (NYSE:NES) from $4.50 to $3.50 in a research report […]
-
Hot Watch List: Biogen Idec Inc. (NASDAQ:BIIB), Salix Pharmaceuticals (NASDAQ:SLXP), State Bank Financial Corporation (NASDAQ:STBZ), Huntington Bancshares Incorporated (NASDAQ:HBAN), Energizer (NYSE:ENR)
Biogen Idec Inc. (NASDAQ:BIIB) announced that it presented at the Cowen and Company 35th Annual Healthcare Conference, on Monday, March 2, 2015 at 2:50 p.m. ET. On Wednesday shares of Biogen Idec Inc. (NASDAQ:BIIB) closed at $408.11. Company’s sales growth for last 5 years was 17.30% and EPS growth for next 5 years is recorded […]
-
Market Watch List: Verso Corporation (NYSE:VRS), Goldcorp Inc. (NYSE:GG), Cedar Realty Trust (NYSE:CDR), Biogen Idec Inc. (NASDAQ:BIIB), Zynga Inc (NASDAQ:ZNGA)
Verso Corporation (NYSE:VRS) is reporting financial losses for both the fourth quarter and the year ended Dec. 31, 2014, citing as factors a 2.7% decrease in average sales price per ton and a 4.3% decline in total sales volume. Net sales for 2014 decreased 6.6% to $1,296.6 million from $1,388.9 million in 2013, due to […]
-
Top Morning News: Bankrate (NYSE:RATE), Biogen Idec Inc. (NASDAQ:BIIB), EMC Corporation (NYSE:EMC), ArcelorMittal SA (ADR) (NYSE:MT), Comstock Resources Inc. (NYSE:CRK)
On 2 March 2015, Bankrate, Inc. (NYSE:RATE) reported that as per a new Bankrate.com survey report, high medical expenses are Americans’ biggest financial worry about retirement. Data collected by Princeton Survey Research Associates International for the Bankrate’s poll revealed that the highest-income households (over $75,000 per year) are more concerned about high medical expenses than […]
-
Ever Green Stocks: Biogen Idec Inc. (NASDAQ:BIIB), Merrimack Pharmaceuticals (NASDAQ:MACK), The Chubb Corporation (NYSE:CB), Popeyes Louisiana Kitchen (NASDAQ:PLKI), 8×8 Inc. (NASDAQ:EGHT)
Biogen Idec Inc. (NASDAQ:BIIB) and Sobi have announced positive clinical trial data demonstrating the benefits their haemophilia B therapy can offer to paediatric patients. Top-line results have been reported from the Kids B-LONG phase III clinical study, which evaluated the safety, efficacy and pharmacokinetics of Alprolix in children under age 12 with severe haemophilia B. […]
-
Watch 5 Stocks: Biogen Idec Inc. (NASDAQ:BIIB), Lumber Liquidators Holdings (NYSE:LL), LinkedIn Corporation (NYSE:LNKD), Five9 (NASDAQ:FIVN), Citizens Holding Company (NASDAQ:CIZN)
On 27 February, Biogen Idec (NASDAQ:BIIB) and Swedish Orphan Biovitrum AB (publ) (Sobi) (SOBI.ST) announced positive top-line results of the Kids B-LONG Phase 3 clinical study that evaluated the safety, efficacy and pharmacokinetics of Alprolix® [Coagulation Factor IX (Recombinant), Fc Fusion Protein] in children under age 12 with severe haemophilia B. Alprolix was generally well […]
-
Top News: Biogen Idec Inc. (NASDAQ:BIIB), Summit Financial Group Inc. (NASDAQ:SMMF), Oracle Corporation (NYSE:ORCL), Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Caterpillar Inc. (NYSE:CAT)
Shares of Biogen Idec (NASDAQ:BIIB) have been given an average recommendation of “Buy” by the nineteen analysts that are currently covering the company, Stock Ratings Network.com reports . Three research analysts have rated the stock with a hold recommendation and sixteen have issued a buy recommendation on the company. On Friday shares of Biogen Idec […]
-
Top Stocks: The Dow Chemical Company (NYSE:DOW), General Motors (NYSE:GM), Biogen Idec Inc. (NASDAQ:BIIB), HNI Corp. (NYSE:HNI), Diversicare Healthcare Services Inc. (NASDAQ:DVCR)
On February 24, it was reported that, To kick off national Engineers Week, The Dow Chemical Company (NYSE:DOW) and Project Lead The Way (PLTW) announced a significant partnership to increase K-12 students’ access to high-quality science, technology, engineering, and math (STEM) education programs. Through a $400,000 commitment, Dow will fund PLTW programs in 17 schools […]